APA (7th ed.) Citation

Strand, V., Mease, P., Gossec, L., Elkayam, O., van den Bosch, F., Zuazo, J., . . . Mpofu, S. (2017). Secukinumab improves patient-reported outcomes in subjects with active psoriatic arthritis: Results from a randomised phase III trial (FUTURE 1). Annals of the rheumatic diseases, 76(1), 203-207. https://doi.org/10.1136/annrheumdis-2015-209055

Chicago Style (17th ed.) Citation

Strand, Vibeke, Philip Mease, Laure Gossec, Ori Elkayam, Filip van den Bosch, James Zuazo, Luminita Pricop, and Shephard Mpofu. "Secukinumab Improves Patient-reported Outcomes in Subjects with Active Psoriatic Arthritis: Results from a Randomised Phase III Trial (FUTURE 1)." Annals of the Rheumatic Diseases 76, no. 1 (2017): 203-207. https://doi.org/10.1136/annrheumdis-2015-209055.

MLA (9th ed.) Citation

Strand, Vibeke, et al. "Secukinumab Improves Patient-reported Outcomes in Subjects with Active Psoriatic Arthritis: Results from a Randomised Phase III Trial (FUTURE 1)." Annals of the Rheumatic Diseases, vol. 76, no. 1, 2017, pp. 203-207, https://doi.org/10.1136/annrheumdis-2015-209055.